News and Events

12/2021: UGA Biopharma enters partnership with Tosoh Bioscience
UGA Biopharma GmbH has entered a partnership with US-based Tosoh Bioscience LLC to exchange knowledge on upstream and downstream bioprocessing (USP/DSP) more

10/2021: UGA Biopharma to showcase their Cell line development platform at BIO-Europe Digital
UGA Biopharma GmbH, the leading-edge contract development and research organization for biologics and biosimilars, will once again be a high-profile more

05/2021: Tcell Tolerance GmbH assigned UGA Biopharma to develop a highly efficient CHO cell line and bioprocess
UGA Biopharma is developing a new and more efficient CHO-DG44 cell line for German-based startup more

04/2021: Scale-Up of a Biosimilar Production Process
Eppendorf and UGA Biopharma GmbH recently published the application note: “Scale-Up of a Biosimilar Production Process with CHO Cells from Small to more

03/2021: UGA Biopharma at BIO-Europe Spring 2021
UGA Biopharma GmbH will return to the annual BIO-Europe Spring biotech industry partnering conference, hosted in virtual format for 2021.UGA Biopharma, which has a more

03/2021: Russian developer Mabscale in-licensed UGA Biopharma´s biosimilar cell lines
UGA has out-licensed two of its innovative ready-to-use biosimilar cell lines to Russia-based more

12/2020: UGA Biopharma wishes Merry Christmas and a Happy New Year!
Traditionally the Cell line development UGA family gathers all together to celebrate Christmas. Due to more

10/2020: UGA Biopharma presents efficient development of stable high titer cell lines at BIO Europe DIGITAL convention 2020
UGA Biopharma GmbH will present its latest high-performance stable CHO cell lines for high titer production of more

09/2020: UGA Biopharma GmbH participates at the virtual CPhI Festival of Pharma 2020
UGA Biopharma GmbH will participate in the virtual CPhI Festival of Pharma 2020 over eleven days in October. The CPhI Festival will take the form of a more

09/2020: FcR affinity chromatography - a new approach to assess glycan profiles
TOSOH Bioscience and UGA Biopharma did cooperate on a project regarding FcR Affinity chromatography. The outcome of this project is described in the more

09/2020: Case study with Evidentic
Evidentic and UGA Biopharma collaborated for a case study which was recently published on the website of Evidentic, “Aliquots: A New Solution to the more

09/2020: New method for EPO purification patented by UGA Biopharma
We have developed a newly patented method for the purification of the evolutionarily conserved hormone Erythropoietin (EPO) and its more

07/2020: UGA Biopharma to debut at digital Bioprocessing Summit Europe
UGA Biopharma GmbH will make its debut at the upcoming annual Bioprocessing Summit Europe conference, now repurposed as a virtual online event in response more

06/2020: UGA Biopharma at the BIO Digital 2020 meeting
We will take part at the annual BIO International Convention USA 2020 for the first time, which was re-branded BIO Digital because of the coronavirus more

04/2020: UGA Biopharma´s high-speed cell line development workflow
The UGA Biopharma GmbH high-speed workflow was established as an improved cell line development workflow that guarantees CHO cell line development on a more

03/2020: COVID-19 statement from UGA Biopharma GmbH
Dear valued customer, partner and friends of UGA Biopharma GmbH, as all of us, we also closely more

03/2020: Meet UGA Biopharma GmbH at BIO-Europe Spring virtual conference
UGA Biopharma GmbH will present its value-added mammalian cell line development services at the upcoming annual BIO-Europe Spring® biotech industry partnering conference, now to be hosted more

11/2019: Meet our CEO at the CPhI in Frankfurt and Bio-Europe in Hamburg
Do not miss the opportunity to meet Dr. Lars Kober, CEO of UGA Biopharma GmbH at the CPhI in Frankfurt from November 5-8, 2019 as well as at more

09/2019: UGA Biopharma presented the benefits of First CHOice® Media
September 18, 2019: Sarah Herrman, head of the Technology Development Group, presented her data at the conference „New and Emerging Technologies – Biotech meets Medicine“ in Potsdam-Golm. more

05/2019: High Ranking Delegation from China
UGA Biopharma welcomed 28 delegates from China. Representatives from chinese health institutes more

05/2019: ESACT Meeting in Copenhagen
On behalf of all UGA team members, we would like to thank all our customers and partners for their valuable and long-standing more

12/2017: Four projects successfully completed in Q4
Four biosimilar development projects were successfully finalized in Q4. Ready-to-use Research Cell Banks are available for out-licensing now! more

11/2017: New CEO
UGA Biopharma announces that Dr. Lars Kober, who was holding Operational Management for many years took over the management of UGA. more

10/2017: Abzena and UGA Biopharma collaborate to treat MS
See our latest press release using that more

09/2017: First CHOice - product promotion in transkript Vol 9
See the current product promotion for our High-Performance Cell Culture Medium First CHOice® published in transkript journal Vol. 9 page 41 via this more

08/2017: Collaboration between Batavia Biosciences and UGA Biopharma
Both companies have the ambition to provide services and technologies supporting the development of high quality and affordable biopharmaceuticals. Through the partnership, two enzyme expressing more

07/2017: Meet us at "New & Emerging Technologies" in Potsdam
You can meet us at the congress "New & Emerging more

05/2017: UGA Biopharma presented at Bionnale 2017
Pitch presentation "Cell lines for biosimilar and NBE manufacturing + services" more

04/2017: Opening of additional development labs at UGA Biopharma
UGA Biopharma will open additional laboratories featuring state-of-the-art equipment at the Hennigsdorf site for cell line development and analytical contract services. The extension is tailor-made more

03/2017: Launch of High Speed Workflow
UGA has launched an improved cell-line-development workflow ("High Speed Workflow"), which guarantees cell line development on a shortened time more


UGA Biopharma GmbH
Neuendorfstraße 20a
16761 Hennigsdorf
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Phone: +49(0)3302 / 2024900